Loading…
Reported covered position: Director, Senator Chris Dodd; Staff Director
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Food and Drug Administration Safety Over Sequestration Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, S. Con. Res. 11 FY2016 Senate Budget
Food and Drug Administration Safety Over Sequestration Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2016
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2015 · second_quarter · Q2
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2016
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act
Source: Senate LDA
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation, 21st Century Cures Initiative, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations, H.R. 406 Combination Drug Development Incentive Act, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 1576 Generic Complex Drugs Safety and Effectiveness for Patients Act
Medicaid Generic Drug Price Fairness Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act
FAST Generics Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
Combination Drug Development Incentive Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation, 21st Century Cures Initiative, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations, H.R. 406 Combination Drug Development Incentive Act, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 1576 Generic Complex Drugs Safety and Effectiveness for Patients Act
21st Century Cures Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
Innovation Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 9 The Innovation Act, S. 632 STRONG Patents Act
Innovation Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 632 STRONG Patents Act, S. 1137 Patent Act
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation, 21st Century Cures Initiative, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations, H.R. 406 Combination Drug Development Incentive Act, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 1576 Generic Complex Drugs Safety and Effectiveness for Patients Act
PATENT Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 632 STRONG Patents Act, S. 1137 Patent Act
Medicaid Generic Drug Price Fairness Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
STRONG Patents Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 632 STRONG Patents Act, S. 1137 Patent Act
STRONG Patents Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 9 The Innovation Act, S. 632 STRONG Patents Act
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, S. Con. Res. 11 FY2016 Senate Budget
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs, H.R. 1588, Medicare Drug Savings Act of 2013, S. 740, Medicare Drug Savings Act of 2013
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725 Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, H.J. Res. 59 Continuing Appropriations Resolution 2014, S. 1413 FDA User Fee Protection ActS. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 2725, FDA Safety over Sequestration Act of 2013, H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, S. 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, H.R.5016, Financial Services and General Government Appropriations Act, 2015, S. 1413, FDA User Fee Protection Act, FY2016 FDA Budget Request
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725 Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, H.J. Res. 59 Continuing Appropriations Resolution 2014, S. 1413 FDA User Fee Protection ActS. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Combination Drug Development Incentive Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Combination Drug Development Incentive Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Combination Drug Development Incentive Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
MODDERN Cures Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
MODDERN Cures Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
Drug Quality and Security Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Drug Quality and Security Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 3709 Protecting Consumer Access to Generic Drugs Act, S. 214 Preserve Access to Affordable Generics Act, H.R. 3309 Innovation Act
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 3309, Innovation Act, H.R. 3709, Protecting Consumers Access to Generic Drugs Act of 2013, S. 214, Preserve Access to Affordable Generics Act, S. 1720, Patent Transparency and Improvements Act of 2013, S. 2049, Transparency in Assertion of Patents Act, H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 3709 Protecting Consumer Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 - the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 - the Bipartisan Congressional Trade Priorities Act of 2014
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Trans Pacific Partnership, TTIP, TPA, H.R. 3830, the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900, the Bipartisan Congressional Trade Priorities Act of 2014
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Keep the Promise to Seniors Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Keep the Promise to Seniors Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Generic Drug Pricing Fairness Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Generic Drug Pricing Fairness Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
Stop Tampering of Prescription Pills Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Stop Tampering of Prescription Pills Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Stop Tampering of Prescription Pills Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Fair Access for Safe and Timely Generics Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Fair Access for Safe and Timely Generics Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
Medicaid Generic Drug Price Fairness Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs, H.R. 5748 Medicaid Generic Drug Price Fairness Act, S. 2948 Medicaid Generic Drug Price Fairness Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725 Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, H.J. Res. 59 Continuing Appropriations Resolution 2014, S. 1413 FDA User Fee Protection ActS. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 2725, FDA Safety over Sequestration Act of 2013, H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, S. 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, H.R.5016, Financial Services and General Government Appropriations Act, 2015, S. 1413, FDA User Fee Protection Act, FY2016 FDA Budget Request
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Patent Transparency and Improvements Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 3309, Innovation Act, H.R. 3709, Protecting Consumers Access to Generic Drugs Act of 2013, S. 214, Preserve Access to Affordable Generics Act, S. 1720, Patent Transparency and Improvements Act of 2013, S. 2049, Transparency in Assertion of Patents Act, H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013
Patent Transparency and Improvements Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Patent Transparency and Improvements Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Trans Pacific Partnership, TTIP, TPA, H.R. 3830, the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900, the Bipartisan Congressional Trade Priorities Act of 2014
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 - the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 - the Bipartisan Congressional Trade Priorities Act of 2014
Transparency in Assertion of Patents Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
Transparency in Assertion of Patents Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 3309, Innovation Act, H.R. 3709, Protecting Consumers Access to Generic Drugs Act of 2013, S. 214, Preserve Access to Affordable Generics Act, S. 1720, Patent Transparency and Improvements Act of 2013, S. 2049, Transparency in Assertion of Patents Act, H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013
Transparency in Assertion of Patents Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 3709 Protecting Consumer Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 3309, Innovation Act, H.R. 3709, Protecting Consumers Access to Generic Drugs Act of 2013, S. 214, Preserve Access to Affordable Generics Act, S. 1720, Patent Transparency and Improvements Act of 2013, S. 2049, Transparency in Assertion of Patents Act, H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 3709 Protecting Consumer Access to Generic Drugs Act, S. 214 Preserve Access to Affordable Generics Act, H.R. 3309 Innovation Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 2725, FDA Safety over Sequestration Act of 2013, H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, S. 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, H.R.5016, Financial Services and General Government Appropriations Act, 2015, S. 1413, FDA User Fee Protection Act, FY2016 FDA Budget Request
Medicaid Generic Drug Price Fairness Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs, H.R. 5748 Medicaid Generic Drug Price Fairness Act, S. 2948 Medicaid Generic Drug Price Fairness Act
Dormant Therapies Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs, H.R. 1588, Medicare Drug Savings Act of 2013, S. 740, Medicare Drug Savings Act of 2013
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Drug Supply Chain Security Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Drug Supply Chain Security Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Health Care Reform, Implementation of Generic Biologics, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar NamingH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 2725 FDA Safety over Sequestration Act H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R. 3204 Drug Quality and Security Act H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, Pharmaceutical Drug Compounding, Labeling of Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R.3204 Drug Quality and Security Act H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and Generic DrugsH.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, and Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R.1366 -Stop Oxy Abuse Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 S.214 - Preserve Access to Affordable Generics Act S.504 - Fair And Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential Budget Request, FY14 BudgetBills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, And Generic Drugs, Pharmaceutical Drug CompoundingH.R. 486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R. 1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R. 2186 - VALID Compounding Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H. Res. - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S. 504 - Fair and Immediate Release of Generic Drugs Act S. 621 - Safe Prescribing Act of 2013 S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Compounding S. Res. 97 - A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY14 BudgetH.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Bills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023; H.R. 2725 FDA Safety over Sequestration Act; H.J. Res 59 Continuing Appropriations Resolution 2014; S 1413 FDA User Fee Protection Act; HR 2410 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014;S 1244 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014 FY 2014 Budget
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, and Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R.1366 -Stop Oxy Abuse Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 S.214 - Preserve Access to Affordable Generics Act S.504 - Fair And Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic DrugsBills: H.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, Pharmaceutical Drug Compounding, Labeling of Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R.3204 Drug Quality and Security Act H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, And Generic Drugs, Pharmaceutical Drug CompoundingH.R. 486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R. 1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R. 2186 - VALID Compounding Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H. Res. - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S. 504 - Fair and Immediate Release of Generic Drugs Act S. 621 - Safe Prescribing Act of 2013 S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Compounding S. Res. 97 - A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R.1366 - Stop Oxy Abuse Act of 2013 S.214 - Preserve Access to Affordable Generics Act S.504 - Fair And Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
H.R. 9 The Innovation Act, S. 632 STRONG Patents Act, S. 1137 Patent Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2015 · first_quarter · Q1
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation, 21st Century Cures Initiative, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations, H.R. 406 Combination Drug Development Incentive Act, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 1576 Generic Complex Drugs Safety and Effectiveness for Patients Act
Patent Reform, H.R. 9 The Innovation Act, S. 632 STRONG Patents Act
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, S. Con. Res. 11 FY2016 Senate Budget
Medicare Part D Program and Generic Drugs, Medicare Part D Non-Interference, Prescription Drug Pricing, Low-Income Subsidy in Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · fourth_quarter · Q4
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
H.R. 83 Consolidated and Further Continuing Appropriations Act
H.R. 3709 Protecting Consumer Access to Generic Drugs Act, S. 214 Preserve Access to Affordable Generics Act, H.R. 3309 Innovation Act
Medicare Part D Program and Generic Drugs, H.R. 5748 Medicaid Generic Drug Price Fairness Act, S. 2948 Medicaid Generic Drug Price Fairness Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · third_quarter · Q3
H.R. 4800 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
Medicare Part D Program and Generic Drugs
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
H.R. 3709 Protecting Consumer Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · second_quarter · Q2
Trans Pacific Partnership, TTIP, TPA, H.R. 3830, the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900, the Bipartisan Congressional Trade Priorities Act of 2014
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
H.R. 3309, Innovation Act, H.R. 3709, Protecting Consumers Access to Generic Drugs Act of 2013, S. 214, Preserve Access to Affordable Generics Act, S. 1720, Patent Transparency and Improvements Act of 2013, S. 2049, Transparency in Assertion of Patents Act, H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013
Medicare Part D Program and Generic Drugs, H.R. 1588, Medicare Drug Savings Act of 2013, S. 740, Medicare Drug Savings Act of 2013
H.R. 2725, FDA Safety over Sequestration Act of 2013, H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, S. 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, H.R.5016, Financial Services and General Government Appropriations Act, 2015, S. 1413, FDA User Fee Protection Act, FY2016 FDA Budget Request
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · first_quarter · 1A
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725 Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, H.J. Res. 59 Continuing Appropriations Resolution 2014, S. 1413 FDA User Fee Protection ActS. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · first_quarter · Q1
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 - the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 - the Bipartisan Congressional Trade Priorities Act of 2014
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2013 · fourth_quarter · Q4
S. 214 - Preserve Access to Affordable Generics Act; S.504 - Fair and Immediate Release of Generic Drugs Act, H.R. 3309 Innovation Act, HR 3709 Protecting Consumers Access to Generic Drugs Act of 2013
Free Trade Agreements-Trans Pacific Partnership
Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D ProgramH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 1588 - Medicare Drug Savings Act of 2013 S.740 - Medicare Drug Savings Act of 2013 S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2013 · third_quarter · Q3
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential BudgetH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 2725 FDA Safety over Sequestration Act S. 1413 FDA User Fee Protection Act HR 2410 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014 S 1244 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014
FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic DrugsH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 1588 - Medicare Drug Savings Act of 2013 S.740 - Medicare Drug Savings Act of 2013
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2013 · second_quarter · Q2
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic DrugsBills: H.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, And Generic Drugs, Pharmaceutical Drug CompoundingH.R. 486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R. 1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R. 2186 - VALID Compounding Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H. Res. - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S. 504 - Fair and Immediate Release of Generic Drugs Act S. 621 - Safe Prescribing Act of 2013 S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Compounding S. Res. 97 - A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2013 · first_quarter · Q1
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, and Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R.1366 -Stop Oxy Abuse Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 S.214 - Preserve Access to Affordable Generics Act S.504 - Fair And Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY14 BudgetH.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2012 · fourth_quarter · Q4
Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
FY 2014 Budget, FY 2013 Budget, Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY12 and FY13 Budget H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 H.J.RES.117 - Continuing Appropriations Resolution, 2013 H.RES.778 - Providing for consideration of the joint resolution (H.J. Res. 117) making continuing appropriations for fiscal year 2013 S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2012 · third_quarter · Q3
Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY12 and FY13 Budget H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 H.J.RES.117 - Continuing Appropriations Resolution, 2013 H.RES.778 - Providing for consideration of the joint resolution (H.J. Res. 117) making continuing appropriations for fiscal year 2013 S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2012 · second_quarter · Q2
Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R.2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R.3839 - Drug Shortage Prevention Act of 2012 H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R.3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R.4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011 S.1734 - Generating Antibiotic Incentives Now Act of 2011 S.2295 - Patient Safety and Generic Labeling Improvement Act S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2012 · first_quarter · Q1
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R.2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3497 - MODDERN Cures Act of 2011 H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R.3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R.4332 - Generic Drug Application Review Fairness Act of 2012 S.27 Preserve Access to Affordable Generics Act S.373 Fair Prescription Drug Competition Act S.1734 - Generating Antibiotic Incentives Now Act of 2011 S. 1882 - The Fair and Immediate Release of Generic Drugs Act
FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs S.44 Medicare Prescription Drug Negotiation Act S.1356 - Affordable Medicines Utilization Act of 2011 H.R.3342 - Affordable Medicines Utilization Act of 2011
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2011 · fourth_quarter · Q4
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R.5 Help Efficient, Accessible, Low-cost, Timely Healthcare (Health) Act of 2011 S.23 and H.R.1249 America Invents Act, Sections 10 and 11 (Supplemental Examination) and Section 37 (patent term extension calculation) S.27 Preserve Access to Affordable Generics Act, S.373 Fair Prescription Drug Competition Act S. 1882, the Fair And Immediate Release of Generic Drugs Act
Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2011 · third_quarter · Q3
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R.5 Help Efficient, Accessible, Low-cost, Timely Healthcare (Health) Act of 2011 S.23 and H.R.1249 America Invents Act, Sections 10 and 11 (Supplemental Examination) and Section 37 (patent term extension calculation) S.27 Preserve Access to Affordable Generics Act, S.373 Fair Prescription Drug Competition Act
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY11 and FY12 Budget
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2011 · second_quarter · Q2
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY11 and FY12 Budget
FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs S. 44 - Medicare Prescription Drug Negotiation Act
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R.5 Help Efficient, Accessible, Low-cost, Timely Healthcare (Health) Act of 2011 H.R.2182 Generating Antibiotic Incentives Now Act of 2011 S.23 and H.R.1249 America Invents Act, Sections 10 and 11 (Supplemental Examination) S.27 Preserve Access to Affordable Generics Act S.373 Fair Prescription Drug Competition Act
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2011 · first_quarter · Q1
FY11 and FY12 Budget, Implementation of Health Care Reform, Medicaid Rebates, prescription drug reimbursement, Average Manufacture Price (AMP)/AMP Publication, generic drugs S.44 - Medicare Prescription Drug Negotiation Act
FY 2011 and FY2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, and generic drugs S.44 - Medicare Prescription Drug Negotiation Act S.296 - Preserving Access to Life-Saving Medications Act S.373 - Fair Prescripton Drug Competition Act
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2010 · fourth_quarter · Q4
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2011 Presidential Budget Request, FY2011 Congressional Budget and Appropriations H.R.2997 and S.1406 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 - Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services
Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2010 · third_quarter · Q3
Budget Reconcilliation, Implementation of Health Care Reform, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole" H.R.4213 - American Jobs and Closing Tax Loopholes Act H.R.4899 - War Supplemental S.1315 - Drug Price Competition Act of 2009
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.4899 - War Supplemental Bill, Preserving Access to Affordable Generic Drugs Provision H.R.4213 - American Jobs and Closing Tax Loopholes Act of 2010 S.3677 - Financial Services and General Government Appropriations Act for FY 2011 S.1315 - Drug Price Competition Act of 2009
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2010 · second_quarter · Q2
Health Care Reform, Budget Reconciliation, Implementation of Health Care Reform, Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, 340B Drug Pricing Program, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.3962 - Affordable Health Care for America Act - Title I, Subtitle E - Improvements to Medicare Part D; Title V Subtitle A - Drug Discount for Rural and Other Hospitals; 340B Program Integrity; Title VII Subtitle E - Financing; H.R.3590 - Patient Protection and Affordable Care Act; Title II Subtitle F - Medicaid Prescription Drug Coverage; Title VII Subtitle B - More Affordable Medicines for Children and Underserved Communities H.R.4213 - American Jobs and Closing Tax Loopholes Act of 2010 H.R.4899 - The War Supplemental Bill
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2011 Presidential Budget Request, FY2011 Congressional Budget and Appropriations H.R.2997 and S.1406 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 - Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2010 · first_quarter · Q1
Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.3962 - Affordable Health Care for America Act - Title I, Subtitle E - Improvements to Medicare Part D; Title V Subtitle A - Drug Discount for Rural and Other Hospitals; 340B Program Integrity; Title VII Subtitle E - Financing; H.R.3590 - Patient Protection and Affordable Care Act; Title II Subtitle F - Medicaid Prescription Drug Coverage; Title VII Subtitle B - More Affordable Medicines for Children and Underserved Communities
Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2009 · fourth_quarter · Q4
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2010 Presidential Budget Request, FY2010 Congressional Budget and Appropriations H.R.2997 and S.1406 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 - Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.3962 - Affordable Health Care for America Act, Title V Subtitle C Part 2 - Biosimilars; Subtitle C Part 1 Section 2573 - Protecting Consumer Access to Generic Drugs
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2009 · third_quarter · Q3
Generic Drug User Fees Funding for FDA, including, but not limited to any proposal relating to funding for the Office of Generic Drugs FY2010 Presidential Budget Request FY2010 Congressional Budget and Appropriations
Medicaid Reimbursement Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs Average Manufacture Price (AMP)/AMP Publication Medicare Part D Drug Program, expanding rebates to Part D program
Free Trade Agrements, including but not limited to the Trans-Pacific Partnership FTA Any matters related to international activities with regard to access to generic medicines
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2009 · second_quarter · Q2
Medicaid Reimbursement Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs Average Manufacture Price (AMP)/AMP Publication Medicare Part D Drug Program, expanding rebates to Part D program
Generic Biologics, including but not limited to: H.R.1427, H.R.1548, and S.726 Prescription Drug Safety Counterfeit Drugs/Import Safety/Pedigree, such as: H.R.759 Authorized Generics, including, but not limited to: S.501 and H.R.573 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2009 · first_quarter · Q1
Patent Reform, including but not limited to: S.515, S.610, and H.R.1260 Patent Settlements/Reverse Payments/Exclusionary Payments, including but not limited to: S.369 and H.R1706 Any other matter that relates to access to generic drugs
Generic Drug User Fees Funding for FDA, including by not limited to any proposal relating to funding for the Office of Generic Drugs FY2010 Presidential Budget Request FY2010 Congrssional Budget and Appropriations
Medicaid Reimbursement Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs Average Manufacture Price (AMP)/AMP Publication
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2008 · fourth_quarter · Q4
Medicaid Reimbursement Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs Average Manufacture Price (AMP)/AMP Publication such as H.R.6331
Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree including but not limited to: S.3409 and H.R.5839 Electronic Prescribing Authorized Generics including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2008 · third_quarter · Q3
FDA Congressional Appropriations, including but not limited to H.R. 2638 and H.R.2642 (Emergency Supplemental Bill) Generic Drug User Fees Funding for FDA, including but not limited to: any proposal relating to funding for the Office of Generic Drugs FY2009 Presidential Budget Request
Patent Reform, including but not limited to: S.1145, S.3600, and H.R.1908 Patent Settlements/Reverse Payments, including but not limited to: S.316, H.R.1432, and H.R.1902 Special 301 Report International Intellectual Property Issues Patent Process Issues, including but not limited to: S.3560, H.R.1778 and H.R.6344 Any other matter that relates to access to generic drugs
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2008 · second_quarter · Q2
Free Trade Agreements, including but not limited to: Colombia, Panama, and Korea Implementation of Peru Trade Promotion Agreement Special 301 Report Any matters related to international activities with regard to access to generic medicines
FDA Congressional Appropriations, including but not limited to H.R.2642 (Emergency Supplemental Bill) Generic Drug User Fees Funding for FDA, including but not limited to: any proposal relating to funding for the Office of Generic Drugs FY2009 Presidential Budget Request
Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Amendments Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree Electronic Prescribing (E-Prescribing) Authorized Generics including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matters that relates to access to generic drugs
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2008 · first_quarter · Q1
Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Amendments Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree Authorized Generics including but not limited to: S.438 and H.R.806 Electronic Prescribing (E-Prescribing), including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matter that relates to access to generic drugs
FDA Congressional Appropriations Any other matter that relates to access to generic drugs Generic Drug User Fees Funding for FDA, including but not limited to: any proposal relating to funding for the Office of Generic Drugs FY2009 Presidential Budget Request
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2007 · year_end · YY
Peru Free Trade Agreement - H.R.3688 Korea Free Trade Agreement Panama Free Trade Agreement Colombia Free Trade Agreement
Patent Reform - S.1195 and H.R.1908 Patent Settlements - S.316, H.R.1432, and H.R.1902
Office of Generic Drugs - S.1859, H.R.2764, H.R.3161, and
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2007 · mid_year · MM
Korea Free Trade Agreement Panama Free Trade Agreement Peru Free Trade Agreement Columbia Free Trade Agreement
Patent Reform - S.1195 and H.R.1908 Patent Settlements - S.316, H.R.1432 and H.R. 1902
Office of Generic Drugs Appropriations - S.1859 and H.R. 3161
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Vice President of the U.S., White House Office
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR), White House Office
Implementation of Health Care Reform, Implementation of Generic Biologics, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar NamingH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 2725 FDA Safety over Sequestration Act H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R. 3204 Drug Quality and Security Act H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
Bills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023; H.R. 2725 FDA Safety over Sequestration Act; H.J. Res 59 Continuing Appropriations Resolution 2014; S 1413 FDA User Fee Protection Act; HR 2410 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014;S 1244 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014 FY 2014 Budget
Filing targets: Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, Pharmaceutical Drug Compounding, Labeling of Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R.3204 Drug Quality and Security Act H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act
Filing targets: Congressional Budget Office (CBO), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic DrugsH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 1588 - Medicare Drug Savings Act of 2013 S.740 - Medicare Drug Savings Act of 2013
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential Budget Request, FY14 BudgetBills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023
Free Trade Agreements-Trans Pacific Partnership, Generic Medicines
Filing targets: Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE, U.S. Trade Representative (USTR)
Free Trade Agreements-Trans Pacific Partnership, Anti-Counterfeiting Trade Agreement (ACTA), Generic Drugs
FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and Generic DrugsH.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R.1366 - Stop Oxy Abuse Act of 2013 S.214 - Preserve Access to Affordable Generics Act S.504 - Fair And Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013
Filing targets: Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
FY 2014 Budget, FY 2013 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs H.R. 3342 - Affordable Medicines Utilization Act of 2011 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 1356 - Affordable Medicines Utilization Act of 2011 S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3497 - MODDERN Cures Act of 2011 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S. 27 Preserve Access to Affordable Generics Act S. 373 Fair Prescription Drug Competition Act S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 1882 - The Fair and Immediate Release of Generic Drugs Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act
FY 2014 Budget, FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R. 3839 - Drug Shortage Prevention Act of 2012 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 H.R.6584 - Verifying Authority and Legality In Drug Compounding Act of 2012 H.R.6611 - Patient Access to Drugs in Shortage Act of 2012 H.R.6638 - S.A.F.E. Compounded Drugs Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 296 and H.R.2245 Preserving Access to Life-Saving Medication Act S. 373 Fair Prescription Drug Competition Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 2295 - Patient Safety and Generic Labeling Improvement Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs H.R. 3342 - Affordable Medicines Utilization Act of 2011 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 1356 - Affordable Medicines Utilization Act of 2011 S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011
FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R. 3839 - Drug Shortage Prevention Act of 2012 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 H.R.6160 - Stop Tampering of Prescription Pills Act of 2012 H.R. 6433 - FDA User Fee Corrections Act of 2012 S. 44 Medicare Prescription Drug Negotiation Act S. 296 and H.R.2245 Preserving Access to Life-Saving Medication Act S. 373 Fair Prescription Drug Competition Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 2295 - Patient Safety and Generic Labeling Improvement Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act S.1855 - Pandemic and All-Hazards Preparedness Act Reauthorization of 2011
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R. 3497 - MODDERN Cures Act of 2011 H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R. 4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S. 27 Preserve Access to Affordable Generics Act S. 373 Fair Prescription Drug Competition Act S. 1734 - Generating Antibiotic Incentives Now Act of 2011 S. 1882 - The Fair and Immediate Release of Generic Drugs Act S. 2516 - Food and Drug Administration Safety and Innovation Act S. 3187 Food and Drug Administration Safety and Innovation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic Drugs H.R.2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3497 - MODDERN Cures Act of 2011 H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R.3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R.4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.27 Preserve Access to Affordable Generics Act S.373 Fair Prescription Drug Competition Act S.1734 - Generating Antibiotic Incentives Now Act of 2011 S. 1882 - The Fair and Immediate Release of Generic Drugs Act S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act
FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs H.R.3342 - Affordable Medicines Utilization Act of 2011 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.44 Medicare Prescription Drug Negotiation Act S.1356 - Affordable Medicines Utilization Act of 2011 S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY12 and FY13 Budget H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY12 and FY13 Budget H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012
FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, and generic drugs Bills: H.R.2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R.3839 - Drug Shortage Prevention Act of 2012 H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R.3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R.4332 - Generic Drug Application Review Fairness Act of 2012 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011 S.1734 - Generating Antibiotic Incentives Now Act of 2011
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY11 and FY12 Budget
FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011
FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs S.44 Medicare Prescription Drug Negotiation Act S.1356 - Affordable Medicines Utilization Act of 2011 H.R.3342 - Affordable Medicines Utilization Act of 2011
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Average Manufacture Price (AMP)/AMP Publication, and generic drugs S.44 Medicare Prescription Drug Negotiation Act S.1356 - Affordable Medicines Utilization Act of 2011
FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011
Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
FY 2011 and FY 2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug User Fees, Authorized Generics, Prescription Drug Importation/Re-Importation, and generic drugs H.R. 2182 Generating Antibiotic Incentives Now Act of 2011 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act
Free Trade Agreements-Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs H.R.5 - Help Efficient, Accessible, Low-cost, Timely Healthcare (Health) Act of 2011 S.23 and H.R.1249 - America Invents Act, Sections 10 and 11 (Supplemental Examination) S.27 - Preserve Access to Affordable Generics Act, all provisions S.373 - Fair Prescription Drug Competition Act
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY11 and FY12 Budget
Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Budget Reconciliation, Implementation of Health Care Reform, Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, 340B Drug Pricing Program, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.4213 - American Jobs and Closing Tax Loopholes Act of 2010 H.R.4899 - The War Supplemental Bill
Budget Reconcilliation, Implementation of Health Care Reform, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole" H.R.4213 - American Jobs and Closing Tax Loopholes Act H.R.4899 - War Supplemental S.1315 - Drug Price Competition Act of 2009
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.4899 - War Supplemental Bill, Preserving Access to Affordable Generic Drugs Provision H.R.4213 - American Jobs and Closing Tax Loopholes Act of 2010 S.3677 - Financial Services and General Government Appropriations Act for FY 2011 S.1315 - Drug Price Competition Act of 2009
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2011 Presidential Budget Request, FY2011 Congressional Budget and Appropriations H.R.2997 and S.1406 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 - Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services
Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
Budget Reconciliation, Implementation of Health Care Reform, Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, 340B Drug Pricing Program, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.4213 - American Jobs and Closing Tax Loopholes Act of 2010 H.R.4899 - The War Supplemental Bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office
Generic Biologics, Health Care Reform, Budget Reconcilliation, Implementation of Health Care Reform Bill, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies; Section 10609 Generic Drug Labeling H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole" H.R.4213 - American Jobs and Closing Tax Loopholes Act H.R.4899 - War Supplemental Bill
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.3962 - Affordable Health Care for America Act, Title V Subtitle C Part 2 - Biosimilars; Subtitle C Part 1 Section 2573 - Protecting Consumer Access to Generic Drugs H.R.4899 - War Supplemental Bill, Preseving Access to Affordable Generic Drugs Provision H.R.4213 - American Jobs and Closing Tax Loopholes Act of 2010
Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.3962 - Affordable Health Care for America Act, Title V Subtitle C Part 2 - Biosimilars; Subtitle C Part 1 Section 2573 - Protecting Consumer Access to Generic Drugs
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2011 Presidential Budget Request, FY2011 Congressional Budget and Appropriations The President's FY2011 Budget Request to Congress H.R.4872 - Reconciliation Bill, Closing the Medicare Prescription Drug "Donut Hole"
Generic Biologics, Health Care Reform, Budget Reconciliation, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies; Section 10609 Generic Drug Labeling H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole"
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.3962 - Affordable Health Care for America Act - Title I, Subtitle E - Improvements to Medicare Part D; Title V Subtitle A - Drug Discount for Rural and Other Hospitals; 340B Program Integrity; Title VII Subtitle E - Financing; H.R.3590 - Patient Protection and Affordable Care Act; Title II Subtitle F - Medicaid Prescription Drug Coverage; Title VII Subtitle B - More Affordable Medicines for Children and Underserved Communities
Generic Biologics, Health Care Reform, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
Patent Reform, including, but not limited to: S.515, S.610, and H.R.1260 Patent Settlements/Reverse Payments/Exclusionary Payments, including, but not limited to: S.369 and H.R.1706 Legislation relating to patent term extensions Any other matter that relates to access to generic drugs
Generic Biologics, including but not limited to: H.R.1427, H.R.1548, and S.726 Prescription Drug Safety Counterfeit Drugs/Import Safety/Pedigree, such as: H.R.759 Authorized Generics, including, but not limited to: S.501 and H.R.573 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Free Trade Agrements, including but not limited to the Trans-Pacific Partnership FTA Any matters related to international activities with regard to access to generic medicines
Generic Drug User Fees Funding for FDA, including, but not limited to any proposal relating to funding for the Office of Generic Drugs FY2010 Presidential Budget Request FY2010 Congressional Budget and Appropriations
Patent Reform, including, but not limited to: S.515, S.610, and H.R.1260 Patent Settlements/Reverse Payments/Exclusionary Payments, including, but not limited to: S.369 and H.R.1706 Legislation relating to patent term extensions Any other matter that relates to access to generic drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Generic Biologics, including but not limited to: H.R.1427, H.R.1548, and S.726 Prescription Drug Safety Counterfeit Drugs/Import Safety/Pedigree, such as: H.R.759 Authorized Generics, including, but not limited to: S.501 and H.R.573 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs
Free Trade Agreements, including but not limited to the Trans-Pacific Partnership FTA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Patent Reform, including but not limited to: S.1145, S.3600, and H.R.1908 Patent Settlements/Reverse Payments, including but not limited to: S.316, H.R.1432, and H.R.1902 Special 301 Report International Intellectual Property Issues Patent Process Issues, including but not limited to: S.3560, H.R.1778, and H.R.6344 Any other matter that relates to acess to generic drugs
Free Trade Agreements, including but not limited to: Colombia, Panama, and Korea Implementation of the Peru Trade Promotion Agreement Special 301 Report Any matters related to international activities with regard to access of generic medicines
FDA Congressional Appropriations, including but not limited to: H.R.2638 and H.R.2642 (Emergency Supplemental Bill) Generic Drug User Fees Funding for FDA, including but not limited to: any proposal relating to funding for the Office of Generic Drugs FY2009 and 2010 Presidential Budget Request
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree including but not limited to: S.3409 and H.R.5839 Electronic Prescribing (E-Prescribing) Authorized Generics including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs
Free Trade Agreements, including but not limited to: Colombia, Panama, and Korea Implementation of Peru Trade Promotion Agreement Special 301 Report Any matters related to international activities with regard to access of generic medicines
Medicaid Reimbursement Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs Average Manufacture Price (AMP)/AMP Publication such as H.R.6331
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Medicaid Reimbursement All provisions relating to access to generic medicine Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs Average Manufacture Price (AMP)/AMP Publication such as H.R.6331
Patent Reform, including but not limited to: S.1145 and H.R.1908 Patent Settlements/Reverse Payments, including but not limited to: S.316, H.R.1432, and H.R.1902 Special 301 Report Patent Process Issues, including but not limited to: H.R.1778 and H.R.6344 International Intellectual Property Issues Any other matter that relates to access to generic drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Free Trade Agreements, including but not limited to: Colombia, Panama, Korea Special 301 Report Any matters related to international activities with regrad to access to generic medicines
Patent Reform, including but not limited to: S.1145 and H.R.1908 Patent Settlements/Reverse Payments, including but not limited to: S.316, H.R.1432, and H.R.1902 Special 301 Report International Intellectual Property Issues Any other matter that relates to access to generic drugs
Medicaid Reimbursement All provisions relating to access to generic medicine Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Generic Biologics - S.623, S.1695, H.R.1038, and H.R.1956 Pediatric Exclusivity - S.1082, H.R.2900, and H.R.3580 Drug Safety - S.484, S.1082, H.R.3580 Authorized Generics - S.438 and H.R.806 Citizen Petitions - S.1088, S.25, and H.R.3580 Import Safety - H.R.3610 Counterfeit Drugs - S.242, S.1082, H.R.780, H.R.2710, H.R.3580, and H.R.3610
Medicaid Reimbursement - S.1951, H.R.3140, and H.R.3700 S-Chip/Rebates - S.1893 and H.R.3162
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Generic Biologics - S.623, S.1695, H.R. 1038, and H.R. 1956 Pediatric Exclusivity - S.1082 and H.R. 2900 Drug Safety - S.484 and S.1082 Authorized Generics - S.438 and H.R. 806 Citizen Petitions - S.1088 and S.25 Counterfeit Drugs - S.242, S.1082, H.R. 780 and H.R.2710
Medicaid Reimbursement - S.1951 and H.R.3140 S-Chip/Rebates - S.1893 and H.R. 3162
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)